Gateway Wealth Partners LLC Sells 8,607 Shares of Medical Properties Trust, Inc. (NYSE:MPW)

Gateway Wealth Partners LLC lessened its position in Medical Properties Trust, Inc. (NYSE:MPW) by 44.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,559 shares of the real estate investment trust’s stock after selling 8,607 shares during the quarter. Gateway Wealth Partners LLC’s holdings in Medical Properties Trust were worth $46,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Versant Capital Management Inc boosted its holdings in shares of Medical Properties Trust by 435.0% in the 2nd quarter. Versant Capital Management Inc now owns 7,972 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 6,482 shares in the last quarter. Future Financial Wealth Managment LLC purchased a new position in shares of Medical Properties Trust in the 1st quarter worth about $38,000. Iron Horse Wealth Management LLC boosted its holdings in shares of Medical Properties Trust by 166.7% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 8,000 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 5,000 shares in the last quarter. Fidelis Capital Partners LLC purchased a new position in shares of Medical Properties Trust in the 1st quarter worth about $43,000. Finally, Gateway Investment Advisers LLC purchased a new position in shares of Medical Properties Trust in the 2nd quarter worth about $45,000. Hedge funds and other institutional investors own 71.79% of the company’s stock.

Insider Buying and Selling at Medical Properties Trust

In other Medical Properties Trust news, Director Elizabeth N. Pitman purchased 8,087 shares of the stock in a transaction on Wednesday, September 18th. The stock was acquired at an average price of $6.01 per share, with a total value of $48,602.87. Following the transaction, the director now directly owns 76,740 shares of the company’s stock, valued at approximately $461,207.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Elizabeth N. Pitman sold 10,025 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $4.98, for a total value of $49,924.50. Following the completion of the transaction, the director now owns 68,653 shares of the company’s stock, valued at approximately $341,891.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elizabeth N. Pitman bought 8,087 shares of the firm’s stock in a transaction dated Wednesday, September 18th. The stock was purchased at an average cost of $6.01 per share, with a total value of $48,602.87. Following the transaction, the director now directly owns 76,740 shares in the company, valued at approximately $461,207.40. The disclosure for this purchase can be found here. 1.53% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

MPW has been the subject of a number of research reports. Colliers Securities upgraded Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 price objective for the company in a report on Friday, September 13th. Wolfe Research upgraded Medical Properties Trust to a “hold” rating in a report on Monday, September 23rd. BNP Paribas cut Medical Properties Trust from an “outperform” rating to a “neutral” rating and cut their price objective for the stock from $6.00 to $4.00 in a report on Tuesday, July 2nd. Finally, Truist Financial increased their target price on Medical Properties Trust from $5.00 to $6.00 and gave the company a “hold” rating in a report on Friday, September 13th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Medical Properties Trust presently has an average rating of “Hold” and a consensus price target of $5.22.

Medical Properties Trust Trading Down 1.6 %

MPW opened at $5.86 on Tuesday. The business has a 50 day simple moving average of $5.04 and a two-hundred day simple moving average of $4.80. The firm has a market capitalization of $3.51 billion, a price-to-earnings ratio of -2.64, a PEG ratio of 0.84 and a beta of 1.28. The company has a debt-to-equity ratio of 1.51, a current ratio of 2.93 and a quick ratio of 2.93. Medical Properties Trust, Inc. has a one year low of $2.92 and a one year high of $6.55.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.75). The business had revenue of $266.60 million during the quarter, compared to analyst estimates of $259.53 million. Medical Properties Trust’s revenue was down 21.0% compared to the same quarter last year. During the same period last year, the firm earned $0.48 earnings per share. Analysts predict that Medical Properties Trust, Inc. will post 0.87 EPS for the current year.

Medical Properties Trust Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 10th. Shareholders of record on Monday, September 9th will be given a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 5.47%. The ex-dividend date of this dividend is Monday, September 9th. Medical Properties Trust’s payout ratio is -14.41%.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.